What is fair balance in pharma promotion?
What fair balance actually requires, why it exists, and where teams most often get it wrong.
Fair balance is the requirement that a promotional piece present risk information with roughly the same weight it gives to benefit claims. If an asset spends thirty seconds on efficacy and two seconds on side effects, that's not fair balance even if the safety information is technically present somewhere on screen.
What it is
The rule is simple to state and harder to execute: benefit and risk information need comparable prominence, comparable duration (for video or audio), and comparable clarity (font size, contrast, pacing). A regulator isn't just checking that a risk statement exists. They're checking whether an average viewer would actually absorb it at the same rate they absorbed the benefit claim next to it.
This shows up differently by format. In a video, it's about how long the safety information stays on screen and whether it's legible at that duration. In print, it's about font size and placement relative to the headline claim. In digital, it's about whether a safety disclosure requires an extra click that a benefit claim doesn't.
Why it matters
Fair balance is one of the most common reasons a promotional asset gets rejected or delayed in MLR review, and it's rarely because someone left the safety information out entirely. It's almost always a proportion problem: the creative direction emphasized the benefit, and the safety content got compressed to fit around it instead of being designed in from the start.
That compression is exactly what slows a review cycle down. A reviewer who has to ask "is this actually proportionate" is a reviewer who has to escalate a judgment call, not just check a box. Assets designed with fair balance as a constraint from the first draft, rather than a compliance pass applied afterward, tend to move through review faster for that reason alone.
How it actually works
A few concrete patterns worth knowing:
- Video and audio: the safety information generally needs to run long enough, and at a pace slow enough, to be understood by an average viewer, not just technically present in the runtime.
- Print and static digital: font size and contrast for risk information should be comparable to the benefit claim it's balancing, not a smaller footnote treatment.
- Interactive formats: if a benefit claim is one tap away, the corresponding risk information generally needs to be similarly accessible, not buried three menus deep.
None of this is universal law across every market. What counts as sufficiently prominent varies by jurisdiction and by the specific regulatory guidance a brand's legal and regulatory team is working from. Treat the patterns above as the general shape of the requirement, not a specific legal threshold.
Common misunderstandings
A common misread is treating fair balance as satisfied once a safety slide or a disclosure exists anywhere in the asset. Presence isn't the bar. Proportion is. The second common misread is treating fair balance as a fixed ratio (a certain number of seconds per claim). It's a judgment about comparable weight and comparable comprehension, not a formula, which is exactly why it needs a real review rather than a checklist alone.